First Time Loading...

NLS Pharmaceutics AG
NASDAQ:NLSP

Watchlist Manager
NLS Pharmaceutics AG Logo
NLS Pharmaceutics AG
NASDAQ:NLSP
Watchlist
Price: 0.1423 USD 0.57%
Updated: May 10, 2024
NLSP
/
Cash Flow Statement
/
Cash from Financing Activities

NLS Pharmaceutics AG
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

NLS Pharmaceutics AG
Cash from Financing Activities Peer Comparison

Comparables:
NOVN
ROG
S
SDZ

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
NLS Pharmaceutics AG
NASDAQ:NLSP
Cash from Financing Activities
$17.4m
CAGR 3-Years
249%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Novartis AG
SIX:NOVN
Cash from Financing Activities
-$10.2B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
-1%
Roche Holding AG
SIX:ROG
Cash from Financing Activities
-CHf4.2B
CAGR 3-Years
24%
CAGR 5-Years
17%
CAGR 10-Years
12%
S
Sandoz Group AG
SIX:SDZ
Cash from Financing Activities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is NLS Pharmaceutics AG's Cash from Financing Activities?
Cash from Financing Activities
17.4m USD

Based on the financial report for Dec 31, 2022, NLS Pharmaceutics AG's Cash from Financing Activities amounts to 17.4m USD.

What is NLS Pharmaceutics AG's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
21%

Over the last year, the Cash from Financing Activities growth was -14%. The average annual Cash from Financing Activities growth rates for NLS Pharmaceutics AG have been 249% over the past three years , 21% over the past five years .

ALPHA SPREAD
Join more than 136,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.